摘要 |
Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases. |
申请人 |
PANMIRA PHARMACEUTICALS, LLC |
发明人 |
HUTCHINSON JOHN, HOWARD;PRASIT PETPIBOON, PEPPI;STEARNS BRIAN, ANDREW;EVANS JILLIAN, F.;MORAN MARK;LI YIWEI;WANG BOWEI;TRUONG YEN, PHAM;ROPPE JEFFREY, ROGER;SCOTT JILL, MELISSA;ZUNIC JASMINE, ELEANOR;ARRUDA JEANNIE, M.;SEIDERS THOMAS, JON;STOCK NICHOLAS, SIMON;HADDACH MUSTAPHA |